A recent investigation even revealed that disruptions in gut microbiome composition can modify immune pathways, leading to the tauopathy underlying Alzheimer’s disease in an APOE genotype-dependent manner (Seo et al., 2023). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.